Arcellx Inc
NASDAQ:ACLX 4:00:00 PM EDT
Market Cap (Intraday) | 3.64B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $70.23 |
50-Day MA | $65.35 |
200-Day MA | $46.62 |
Arcellx Inc Stock, NASDAQ:ACLX
25 West Watkins Mill Road, Suite A, Gaithersburg, Maryland 20878
United States of America
Phone: +1.240.327.0603
Number of Employees: 130
Description
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.